(Q48299852)

10 February 2018

title

First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model (English)

1 reference

10 February 2018

1

Robert A Kloner

1 reference

10 February 2018

author name string

Joan S Dow

series ordinal

2

1 reference

10 February 2018

Anil Bhandari

series ordinal

3

1 reference

10 February 2018

publication date

30 December 2010

1 reference

10 February 2018

Journal of Cardiovascular Pharmacology and Therapeutics

published in

1 reference

10 February 2018

volume

16

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

192-196

1 reference

10 February 2018

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other cardioprotective compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Effect of sotalol against reperfusion-induced arrhythmias in Sprague-Dawley and Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Late sodium current inhibition as a new cardioprotective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Ranolazine: an anti-anginal drug with further therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410386485

21 January 2018

Identifiers

DOI

10.1177/1074248410386485

1 reference

10 February 2018

1 reference

10 February 2018